Yajun Xu is the Sr. Vice President of Corporate development at Shangphama Incorporation & ChemPartner Corporation US , currently located in Waltham , MA , USA . Previously , Yajun was the Vice President of biology and pre-clinical development at Shanghai ChemPartner ( one of the business units of Shangpharma ) since April , 2007 to Jan . 2009 . She has established biology and pre-clinical service capabilities for Shanghai ChemPartner , in Shanghai , China .
Prior to Chempartner , Yajun was the Director of Research in the Department of Inflammation , Millennium Pharmaceutical Inc . , MA , US . where she worked for 6 years . Yajun led a small molecule inhibitor program and delivered 2 clinical development candidates with one entered into clinic in August 2006 . Yajun’s group responsibilities were providing in vitro biology and pharmacology support for all kinase and enzyme programs , ranging from target identification , validation , enzymology , cellular biochemical assay development , in vitro and ex vivo compound profiling .
Previously , Yajun worked at BASF Bioresearch Corp . ( now Abbott Bioresearch Corp . ) for 5 years in biochemistry department supporting drug discovery programs in both inflammation and oncology . Yajun received her Ph .D . in Biochemistry training in enzymology with professor Robert H . Abeles at Brandeis University in US in 1992 . She obtained three years of postdoctoral training at Harvard School of Public Health in department of Cell Biology and Molecular Toxicology . She received MS and BS degrees in Chemistry from Beijing University of Chemical Technology in China .